Provided are novel heterocyclic sirtuin binding agents, e.g., N-aryl substituted pyridine dicarboxamides, wherein aryl is phenyl or naphthyl, which are useful as sirtuin modulators. Also provided are methods of using the pyridine dicarboxamide compounds for treating sirtuin mediated disorders and conditions, such as diabetes, cancers, and obesity and diseases related to ageing.
提供了一些新型的杂环sirtuin结合剂,例如N-芳基取代的
吡啶二酰胺,其中芳基是苯基或
萘基,它们可用作sirtuin调节剂。还提供了使用
吡啶二酰胺化合物治疗sirtuin介导的疾病和病症,例如糖尿病、癌症、肥胖症和与衰老相关的疾病的方法。